Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study

NCT04384497 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Joakim Dillner

Collaborators